Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience
Background Acute myeloid leukaemia (AML) is treated with intensive induction
chemotherapy (IT) in medically fit patients. In general, obesity was identified as a risk factor …
chemotherapy (IT) in medically fit patients. In general, obesity was identified as a risk factor …
Combined Approach: FFQ, DII, Anthropometric, Biochemical and DNA Damage Parameters in Obese with BMI ≥ 35 kg m−2
M Milić, I Ožvald, K Matković, H Radašević, M Nikolić… - Nutrients, 2023 - mdpi.com
Although obesity with its comorbidities is linked with higher cancer risk, the data on genome
stability in the obese/severely obese are scarce. This is the first study with three DNA …
stability in the obese/severely obese are scarce. This is the first study with three DNA …
High-Fat Diet Induced PPARδ Promotes Self-renewal of Preleukemic Progenitors in Development of Acute Promyelocytic Leukemia
HY Yamada, CV Rao - Cancer Prevention Research, 2024 - AACR
From risk association between acute promyelocytic leukemia (APL) and obese-overweight
individuals, Mazzarella and colleagues hypothesized that a high-fat diet (HFD) promotes …
individuals, Mazzarella and colleagues hypothesized that a high-fat diet (HFD) promotes …
Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (AML) in Obese Patients
FF Yalniz, A Johnson, Y Alnimer… - European Journal of …, 2024 - Wiley Online Library
Background The molecular architecture of acute myeloid leukemia (AML) is heterogeneous.
Obesity has been identified as a risk factor for the development of AML. There remains a …
Obesity has been identified as a risk factor for the development of AML. There remains a …